Number of the records: 1
Prodrug compositions and utility of hydroxamate-based GCPII inhibitors
- 1.0544774 - ÚOCHB 2022 RIV eng P - Patent Document
Slusher, B. S. - Rais, R. - Vávra, Jan - Tichý, Tomáš - Majer, Pavel - Jančařík, Andrej - Tenora, Lukáš
Prodrug compositions and utility of hydroxamate-based GCPII inhibitors.
2021. Owner: The Johns Hopkins University - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 13.07.2021. Patent Number: US11059775
Institutional support: RVO:61388963
Keywords : hydroxamate * prodrugs * GCPII inhibitors
OECD category: Organic chemistry
https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=11059775B2&KC=B2&FT=D&ND=4&date=20210713&DB=&locale=en_EP
Prodrugs of hydroxamate-based GCPII inhibitors and methods of their use for treating a disease or condition are disclosed.
Permanent Link: http://hdl.handle.net/11104/0321584
Number of the records: 1